|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00383 TIANAN MEDICARE
Nominal 
1.050 0.000 (0.000%) | 2025/12 - Final HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 126,291 | 105,975 | 356,080 | 70,441 | 219,419 |
| Net Cash from / (used in) Investing Activities | (268,997) | (134,589) | (178,826) | (98,624) | (185,065) |
| Net Cash from / (used in) Financing Activities | (5,481) | 29,118 | 100,573 | 29,904 | (79,149) |
| Increase / (Decrease) in Cash & Cash Equivalents | (148,187) | 504 | 277,827 | 1,721 | (44,795) |
| Cash & Cash Equivalents at beginning of period | 885,428 | 890,266 | 589,050 | 576,490 | 616,474 |
| Effect of Foreign Exchange Rate Changes | 5,775 | (5,342) | 23,389 | 10,839 | 4,811 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 743,016 | 885,428 | 890,266 | 589,050 | 576,490 |
| Remarks: | Real time quote last updated: 29/04/2026 17:06 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -26,816 |
| %Change | -- |
| EPS / (LPS) | HKD -0.025 |
| NBV Per Share ($) | HKD 1.641 |